Billy AMZAL is a seasoned researcher and consultant in quantitative healthcare, precision medicine, and predictive medicine, with 25 years of experience in drug development and health economics. They currently serve as an Expert for the European Commission and engage with ISPOR as the Member Engagement Co-Chair for Statistical Methods in HEOR. Previously, Billy held senior roles at Certara and the European Food Safety Authority and has co-authored over 100 publications, contributing significantly to HTA and regulatory submissions. They possess a PhD in statistics and have an extensive academic background from prestigious institutions such as École Polytechnique and Université Pierre et Marie Curie.
This person is not in the org chart
This person is not in any teams
This person is not in any offices